Efficient generation of FVII gene knockout mice using CRISPR/Cas9 nuclease and truncated guided RNAs

Scientific Reports

Volumn 6, Issue , 2016, Pages

  An, Liyou ^a   Hu, Yeshu ^a   Chang, Shiwei ^a   Zhu, Xiumei ^a   Ling, Pingping ^a   Zhang, Fenli ^a   Liu, Jiao ^a   Liu, Yanhong ^a   Chen, Yexiang ^a   Yang, Lan ^b   Presicce, Giorgio Antonio ^c   Du, Fuliang ^a,d  

^a NANJING NORMAL UNIVERSITY   (China)

^b Lannuo Biotechnologies Wuxi Inc   (China)

^c ARSIAL   (Italy)

^d Renova Life Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; ENDONUCLEASE; GUIDE RNA; PROTHROMBIN;

ANIMAL; CRISPR CAS SYSTEM; GENE EDITING; GENETICS; METABOLISM; MOUSE; NIH 3T3 CELL LINE; PROCEDURES;

ANIMALS; CRISPR-CAS SYSTEMS; ENDONUCLEASES; FACTOR VII; GENE EDITING; MICE; NIH 3T3 CELLS; PROTHROMBIN; RNA, GUIDE;

EID: 84965121373     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep25199     Document Type: Article

References (35)

1. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
2. Fu, Y. et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31, 822-826 (2013).
3. Li, D. et al. Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat Biotechnol 31, 681-683 (2013).
4. Doudna, J. A. & Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096 (2014).
5. Gaj, T., Gersbach, C. A. & Barbas, C. F., 3rd. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31, 397-405 (2013).
6. Ran, F. A. et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154, 1380-1389 (2013).
7. Shen, B. et al. Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nat Methods 11, 399-402 (2014).
8. Cho, S. W. et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res 24, 132-141 (2014).
9. Tsai, S. Q. et al. Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol 32, 569-576 (2014).
10. Wyvekens, N., Topkar, V. V., Khayter, C., Joung, J. K. & Tsai, S. Q. Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing. Hum Gene Ther 26, 425-431 (2015).
11. Guilinger, J. P., Thompson, D. B. & Liu, D. R. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol 32, 577-582 (2014).
12. Fu, Y., Reyon, D. & Joung, J. K. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs. Methods Enzymol 546, 21-45 (2014).
13. Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M. & Joung, J. K. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol 32, 279-284 (2014).
14. Zhou, J. et al. One-step generation of different immunodeficient mice with multiple gene modifications by CRISPR/Cas9 mediated genome engineering. Int J Biochem Cell Biol 46, 49-55 (2014).
15. Sakurai, T., Watanabe, S., Kamiyoshi, A., Sato, M. & Shindo, T. A single blastocyst assay optimized for detecting CRISPR/Cas9 system-induced indel mutations in mice. BMC Biotechnol 14, 69 (2014).
16. Mizuno, S. et al. Simple generation of albino C57BL/6J mice with G291T mutation in the tyrosinase gene by the CRISPR/Cas9 system. Mamm Genome 25, 327-334 (2014).
17. Horii, T. et al. Validation of microinjection methods for generating knockout mice by CRISPR/Cas-mediated genome engineering. Sci Rep 4, 4513 (2014).
18. Kimura, Y. et al. CRISPR/Cas9-mediated reporter knock-in in mouse haploid embryonic stem cells. Sci Rep 5, 10710 (2015).
19. Tsai, S. Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol 33, 187-197 (2015).
20. Moreno-Mateos, M. A. et al. CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting i vivo. Nat Methods 12, 982-988 (2015).
21. Doench, J. G. et al. Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol 32, 1262-1267 (2014).
22. Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8, 2281-2308 (2013).
23. Wang, H. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153, 910-918 (2013).
24. Wu, Y. et al. Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell 13, 659-662 (2013).
25. Wu, X. et al. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol 32, 670-676 (2014).
26. Iyer, V. et al. Off-target mutations are rare in Cas9-modified mice. Nat Methods 12, 479 (2015).
27. Ma, Y. et al. Heritable multiplex genetic engineering in rats using CRISPR/Cas9. PLoS One 9, e89413 (2014).
28. Fujii, W., Kawasaki, K., Sugiura, K. & Naito, K. Efficient generation of large-scale genome-modified mice using gRNA and CAS9 endonuclease. Nucleic Acids Res 41, e187 (2013).
29. Emeis, J. J. et al. A guide to murine coagulation factor structure, function, assays, and genetic alterations. J Thromb Haemost 5, 670-679 (2007).
30. Rosen, E. D. et al. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature 390, 290-294 (1997).
31. Fujii, W., Onuma, A., Sugiura, K. & Naito, K. Efficient generation of genome-modified mice via offset-nicking by CRISPR/Cas system. Biochem Biophys Res Commun 445, 791-794 (2014).
32. An, L. et al. Efficient cryopreservation of mouse embryos by modified droplet vitrification (MDV). Cryobiology 71, 70-76 (2015).
33. Yang, H., Wang, H. & Jaenisch, R. Generating genetically modified mice using CRISPR/Cas-mediated genome engineering. Nat Protoc 9, 1956-1968 (2014).
34. Chong, L. Molecular cloning - A laboratory manual, 3rd edition. Science 292, 446-446 (2001).
35. Jiang, M. et al. A novel missense mutation close to the charge-stabilizing system in a patient with congenital factor VII deficiency. Blood Coagul Fibrinolysis 22, 264-270 (2011).